BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

75 related articles for article (PubMed ID: 21291947)

  • 21. [Establishment of RNA interfering retrovirus vector targeting CXCR4 gene driven by human prostate-specific antigen promoter and its biological effects on prostate cancer cells].
    Du YF; Xing YF; Zeng FQ; Lu P; Liu XY; Xiao YJ
    Zhonghua Zhong Liu Za Zhi; 2007 Jul; 29(7):489-94. PubMed ID: 18069626
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Effect of a short CAG (glutamine) repeat on human androgen receptor function.
    Ding D; Xu L; Menon M; Reddy GP; Barrack ER
    Prostate; 2004 Jan; 58(1):23-32. PubMed ID: 14673949
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Coexpression of the partial androgen receptor enhances the efficacy of prostate-specific antigen promoter-driven suicide gene therapy for prostate cancer cells at low testosterone concentrations.
    Suzuki S; Tadakuma T; Asano T; Hayakawa M
    Cancer Res; 2001 Feb; 61(4):1276-9. PubMed ID: 11245419
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Phosphorylation/dephosphorylation of androgen receptor as a determinant of androgen agonistic or antagonistic activity.
    Wang LG; Liu XM; Kreis W; Budman DR
    Biochem Biophys Res Commun; 1999 May; 259(1):21-8. PubMed ID: 10334909
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Antiandrogen-like actions of an antioxidant on survivin, Bcl-2 and PSA in human prostate cancer cells.
    Gunawardena K; Campbell LD; Meikle AW
    Cancer Detect Prev; 2005; 29(4):389-95. PubMed ID: 16139439
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A comparison of in vitro and in vivo EDSTAC test battery results for detecting antiandrogenic activity.
    Charles GD; Kan HL; Schisler MR; Bhaskar Gollapudi B; Sue Marty M
    Toxicol Appl Pharmacol; 2005 Jan; 202(1):108-20. PubMed ID: 15589981
    [TBL] [Abstract][Full Text] [Related]  

  • 27. p300 regulates androgen receptor-independent expression of prostate-specific antigen in prostate cancer cells treated chronically with interleukin-6.
    Debes JD; Comuzzi B; Schmidt LJ; Dehm SM; Culig Z; Tindall DJ
    Cancer Res; 2005 Jul; 65(13):5965-73. PubMed ID: 15994976
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Down-regulation of prostate-specific antigen expression by finasteride through inhibition of complex formation between androgen receptor and steroid receptor-binding consensus in the promoter of the PSA gene in LNCaP cells.
    Wang LG; Liu XM; Kreis W; Budman DR
    Cancer Res; 1997 Feb; 57(4):714-9. PubMed ID: 9044850
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Metabolism of the antiandrogenic drug (Flutamide) by human CYP1A2.
    Shet MS; McPhaul M; Fisher CW; Stallings NR; Estabrook RW
    Drug Metab Dispos; 1997 Nov; 25(11):1298-303. PubMed ID: 9351907
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Evaluation of androgen receptor transcriptional activities of some pesticides in vitro.
    Xu LC; Liu L; Ren XM; Zhang MR; Cong N; Xu AQ; Shao JH
    Toxicology; 2008 Jan; 243(1-2):59-65. PubMed ID: 17980950
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Decoy androgen-responsive element DNA can inhibit androgen receptor transactivation of the PSA promoter gene.
    Zhang P; Zhang J; Young CY; Kao PC; Chen W; Jiang A; Zhang L; Guo Q
    Ann Clin Lab Sci; 2005; 35(3):278-84. PubMed ID: 16081584
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Role of coordinated molecular alterations in the development of androgen-independent prostate cancer: an in vitro model that corroborates clinical observations.
    Shi Y; Chatterjee SJ; Brands FH; Shi SR; Pootrakul L; Taylor CR; Datar R; Cote RJ
    BJU Int; 2006 Jan; 97(1):170-8. PubMed ID: 16336351
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Persistent DDT metabolite p,p'-DDE is a potent androgen receptor antagonist.
    Kelce WR; Stone CR; Laws SC; Gray LE; Kemppainen JA; Wilson EM
    Nature; 1995 Jun; 375(6532):581-5. PubMed ID: 7791873
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Steroid hormonal regulation of growth, prostate specific antigen secretion, and transcription mediated by the mutated androgen receptor in CWR22Rv1 human prostate carcinoma cells.
    Attardi BJ; Burgenson J; Hild SA; Reel JR
    Mol Cell Endocrinol; 2004 Jul; 222(1-2):121-32. PubMed ID: 15249132
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Kelthane degradation in the soil by a P. aeruginosa BS827 strain containing plasmid pBS3].
    Golovlëva LA; Pertsova RN; Travkin VM; Grishchenkov VG; Boronin AM
    Izv Akad Nauk SSSR Biol; 1986; (5):747-52. PubMed ID: 3097097
    [No Abstract]   [Full Text] [Related]  

  • 36. Dicofol residues in eggs and carcasses of captive American kestrels.
    Wiemeyer SN; Clark DR; Spann JW; Belisle AA; Bunck CM
    Environ Toxicol Chem; 2001 Dec; 20(12):2848-51. PubMed ID: 11764170
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Evaluation of the impact of in-ovo exposure to dicofol on avian reproduction.
    Kamata R; Shiraishi F; Nakajima D; Takahashi S; Shimizu A
    Environ Toxicol Chem; 2010 Oct; 29(10):2316-22. PubMed ID: 20872696
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Uptake and depuration kinetics of dicofol metabolite 4,4'-dichlorobenzophenone, in the edible Asiatic clam Meretrix meretrix.
    Ivorra L; Cruzeiro C; Chan SK; Tagulao KA; Cardoso PG
    Chemosphere; 2019 Nov; 235():662-669. PubMed ID: 31276879
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Assessing the potential toxic effect of one persistent organic pollutant: non-covalent interaction of dicofol with the enzyme trypsin.
    Liu Y; Cao R; Qin P; Liu R
    Spectrochim Acta A Mol Biomol Spectrosc; 2012 Apr; 89():210-5. PubMed ID: 22261109
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Reproductive and morphological effects of o,p'-dicofol on two generations of captive American kestrels.
    MacLellan KN; Bird DM; Fry DM; Cowles JL
    Arch Environ Contam Toxicol; 1996 Mar; 30(3):364-72. PubMed ID: 8854968
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.